NYSEAMERICAN:ELMD Electromed Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $9.90 -0.16 (-1.59 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range$9.85Now: $9.90▼$10.1550-Day Range N/A52-Week Range$6.05Now: $9.90▼$19.73Volume44,602 shsAverage Volume146,575 shsMarket Capitalization$85.03 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.Read More Beat the Market (BTM) Rank™ 2.5 Analyst's Opinion Consensus RatingElectromed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.00, Electromed has a forecasted upside of 21.2% from its current price of $9.90.Amount of Analyst CoverageElectromed has received no research coverage in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesElectromed has received 177 “outperform” votes. (Add your “outperform” vote.)Underperform VotesElectromed has received 214 “underperform” votes. (Add your “underperform” vote.)Community SentimentElectromed has received 54.73% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Electromed and other stocks. Vote “Outperform” if you believe ELMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ELMD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldElectromed does not currently pay a dividend.Dividend GrowthElectromed does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Electromed insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.96 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:ELMD Previous SymbolNYSEMKT:ELMD CUSIPN/A CIK1488917 Websmartvest.com Phone+1-952-7589299Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees132 Outstanding Shares8,589,000Market Cap$85.03 million Next Earnings Date11/10/2020 (Estimated) OptionableNot Optionable $9.90 -0.16 (-1.59 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ELMD News and Ratings via Email Sign-up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Electromed? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Electromed. When is Electromed's next earnings date? Electromed is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Electromed. How were Electromed's earnings last quarter? Electromed, Inc. (NYSEAMERICAN:ELMD) issued its earnings results on Tuesday, May, 12th. The medical equipment provider reported $0.07 EPS for the quarter, topping the consensus estimate of $0.06 by $0.01. The medical equipment provider earned $8.74 million during the quarter. View Electromed's earnings history. What price target have analysts set for ELMD? 1 analysts have issued 12-month target prices for Electromed's stock. Their forecasts range from $12.00 to $12.00. On average, they anticipate Electromed's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 21.2% from the stock's current price. View analysts' price targets for Electromed. Are investors shorting Electromed? Electromed saw a decline in short interest during the month of August. As of August 14th, there was short interest totaling 301,000 shares, a decline of 16.0% from the July 30th total of 358,400 shares. Based on an average daily volume of 142,000 shares, the days-to-cover ratio is currently 2.1 days. Currently, 4.7% of the company's shares are sold short. View Electromed's Short Interest. Who are some of Electromed's key competitors? Some companies that are related to Electromed include Neuronetics (VMD), Creo Medical Group (CREO), Hamilton Thorne (HTL), Medica Group (MGP), Advanced Oncotherapy (AVO), Patient Home Monitoring (PTQ), MRI Interventions (CLPT), Titan Medical (TMD), Polarean Imaging (POLX), MRI Interventions (MRIC), Protech Home Medical (PHM), Inspiration Healthcare Group (IHC), Kromek Group (KMK), Delcath Systems (DCTH) and Helius Medical Technologies (HSM). View all competitors. What other stocks do shareholders of Electromed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), Crispr Therapeutics (CRSP), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA), Pfizer (PFE), Protalix Biotherapeutics (PLX) and Rigel Pharmaceuticals (RIGL). Who are Electromed's key executives? Electromed's management team includes the following people: Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 63)Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 40)Mr. Bud Reeves, VP of SalesMr. William J. George J.D., Sec. (Age 70)Ms. Kathryn Thompson, VP of Reimbursement What is Electromed's stock symbol? Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD." Who are Electromed's major shareholders? Electromed's stock is owned by a number of institutional and retail investors. Top institutional investors include EAM Investors LLC (2.46%), Bridgeway Capital Management Inc. (1.67%), Cadence Capital Management LLC (1.09%), Essex Investment Management Co. LLC (1.04%), Teton Advisors Inc. (0.72%) and Globeflex Capital L P (0.65%). Company insiders that own Electromed stock include George H Winn and Stephen H Craney. View institutional ownership trends for Electromed. Which institutional investors are selling Electromed stock? ELMD stock was sold by a variety of institutional investors in the last quarter, including Teton Advisors Inc., Essex Investment Management Co. LLC, Bridgeway Capital Management Inc., and Advisor Group Holdings Inc.. View insider buying and selling activity for Electromed. Which institutional investors are buying Electromed stock? ELMD stock was bought by a variety of institutional investors in the last quarter, including EAM Investors LLC, Globeflex Capital L P, Bank of New York Mellon Corp, 1492 Capital Management LLC, Creative Planning, Two Sigma Advisers LP, Nuveen Asset Management LLC, and Charles Schwab Investment Management Inc.. View insider buying and selling activity for Electromed. How do I buy shares of Electromed? Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Electromed's stock price today? One share of ELMD stock can currently be purchased for approximately $9.90. How big of a company is Electromed? Electromed has a market capitalization of $85.03 million. Electromed employs 132 workers across the globe. What is Electromed's official website? The official website for Electromed is smartvest.com. How can I contact Electromed? Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
